Research Affiliations

Research Affliations

Since its inception in 1998, the Arthritis and Autoimmunity Research Centre (AARC) at the University Health Network has combined clinical and applied studies with basic science research to become one of the most comprehensive centres of its kind. Its research team includes leaders in genomic medicine, immunology, health services research, medical imaging, rheumatology, and orthopaedics. AARC scientists are the principals associated with a number of centres and programs including:

Arthritis Centre of Excellence (ACE)
ACE, founded in 1998, is a state-of-the art facility that performs investigative research into autoimmune rheumatic diseases. Experts in rheumatology, immunology, and orthopaedic surgery collaborate under the direction of Dr. Robert Inman.

Arthritis Community Research and Evaluation Unit (ACREU)
ACREU was established in 1992 to study the impact and management of arthritis. Under the direction of Dr. Elizabeth Badley, the multidisciplinary research team seeks to identify deficiencies in existing treatment and support services, and to assist in the development of new policies and programs. ACREU plays a key role in providing critical information to the provincial and federal governments to enhance arthritis care via the health care system.

Canadian Vasculitis Network (CanVasc)
Founded in 2010 by Dr. Christian Pagnoux and Dr. Simon Carette, the Canadian Vasculitis Network integrates research and clinical groups to address the needs of patients with vasculitis. CanVasc organizes referral centers for patients with vasculitis, initiates and promotes research programs on vasculitis, develops awareness programs and serves as the premier vasculitis group to identify the needs and directions in the field of vasculitis care and research.

Rebecca MacDonald Centre for Arthritis & Autoimmune Disease
The Rebecca MacDonald Centre for Arthritis & Autoimmune Disease at Mount Sinai Hospital integrates clinical patient care with innovative, genetics-based research for rheumatic and autoimmune diseases. Under the direction of Dr. Edward Keystone, the Centre is home to the Division of Advanced Therapeutics, the largest and most successful clinical trial program in Canada. The Division is devoted to the study of new and innovative therapies for rheumatic diseases with an emphasis on rheumatoid arthritis, scleroderma, vasculitis and psoriatic arthritis.

The Centre for Prognosis Studies in Rheumatic Diseases
Since its founding in 1996, the Centre for Prognosis Studies in Rheumatic Diseases has been a unique resource for clinical research in rheumatic diseases. It follows large patient bases with defined rheumatic diseases, including lupus and psoriatic arthritis, in long-term prospective studies. Under the direction of Drs. Murray Urowitz and Dafna Gladman, the Centre's Psoriatic Arthritis Clinic has become the largest of its kind in the world. The Lupus Clinic has been following a patient group according to standard protocol since 1970, and currently has 1360 patients enrolled in its registry.